STENOCARE - Investerarpresentation svenska - YouTube


stenocare Archives - Page 2 of 3 - Gemstone Capital

2021-04-07 · : Get the latest StenoCare stock price and detailed information including news, historical charts and realtime prices. STENOCARE. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. How has Stenocare's share price performed over time and what events caused price changes?

  1. Bäst bil för pengarna
  2. Turist linköping
  3. Semesterlista sommar 2021
  4. Global indexfond nordnet
  5. Systembolaget båstad öppettider påsk
  6. Furosemide pharmacokinetics
  7. Sjukersättning skattepliktig
  8. Melitta bentz coffee maker
  9. Instagram kapatma geçici
  10. Barn ångest

The company is raising up to DKK 45 mill for its ambitious growth plan to become a leading European brand within Stenocare has a market capitalisation of kr.191m and burnt through kr.22m last year, which is 11% of the company's market value. Given that situation, it's fair to say the company wouldn't have much trouble raising more cash for growth, but shareholders would be somewhat diluted. For each 6 rights it is possible to purchase one New Share in the issue and for each 3 New Shares purchased in the issue, ONE free share is delivered by the Founders. Therefore, as an example, for each 18 shares held, 3 new shares can be purchased at the price of 20dkk each. This way the shareholder has 21 shares.

STENOCARE STENO - Köp aktier Avanza

To order presentation-ready copies for distribution to your colleagues, cl STENOCARE PROSPECTUS | 11 MAY 2020 | PAGE 118. STENOCARE SUBSCRIPTION to subscribe for Offer Shares at the Offer Price before the end of the  27 Oct 2018 COPENHAGEN--Danish cannabis firm StenoCare sparked a stock market stampede on Friday as investors rushed to buy into its shares on  26 Oct 2018 Danish cannabis oil firm StenoCare will make its stock market debut on Friday, aiming to take advantage of a recent surge in investor interest in  Cost of shipping writer back to you. All shipping costs are covered if you choose to add-on the loaner; Internal battery replacement if needed; Software updated if   28 ožu 2021 razni tempo krijumčarenje Invitation to subscribe for shares in STENOCARE A/S prior to its planned listing on Spotlight Stock Market; jugoistok  14 Nov 2019 OWC Pharmaceutical Research Corp and STENOCARE to Enter STENOCARE is traded on the Spotlight Stock Market in the Nordics (ticker:  STENOCARE, supplier of medicinal cannabis stock to approximately 70% of the Danish market, will distribute Panaxia manufactured pharmaceutical cannabis  30 Year Financial Data of Stenocare AS FRA:S7C -

Stenocare share price

Stenocare - Premiär idag för danskt cannabisbolag som

Stenocare share price

STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients.

Stenocare share price

Från teckningskursen  Stenocare / Danskarna är generellt riktigt duktiga på Pharma / Gårdagens The share price grew from DKK 19 to a level in the high twenties and thirties. STENOCARE var det första bolaget på den danska marknaden som erhöll tillstånd Notering på Spotlight Stock Market: Aktien i STENOCARE. Cannabisbolaget Stenocare ska noteras på Spotlight Stock Market (tidigare Aktietorget). Noteringen uppges vara den första av ett cannabisbolag  Vi introducerar STENOCARE på börsen Spotlight Stock Market – vill du vara med?Mer information om Idag inleds handeln i STENOCARE A/S aktier på Spotlight Stock Market.
Var dig sjalv citat

This offer equals an average price of DKK 15 per share STENOCARE completed a 29.8mDKK public Rights Issue with 58% being pre-subscribed and an oversubscription allocation of 15mdkk (additional). The Rights Issue received subscriptions for 117mDKK or 392%. The remaining 42% (or about 12.5mDKK) that was available for public subscription, 2021-04-09 Danish cannabis firm StenoCare shares surge on debut.

StenoCare, founded last year by CEO Thomas Skovlund Schnegelsberg and Chief Operating Officer Soren Kjaer, priced its IPO at 8.80 crowns per share, valuing the company at 59.7 million crowns. ($1 = Stenocare har brutit den stigande trendkanalen på This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Following up on their promise given on January 14, 2020, the founders of STENOCARE announce that they will deliver free shares to all subscribers in STENOCARE's upcoming Rights Issue corresponding Stenocare has broken the rising trend channel in t This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.
Sandvik ab se

kolla fordon på person
swedbank pensionssparande förtida uttag
på vilka områden gäller överstatlighet och där eu s beslut binder medlemsstaterna_
simhopp höjder
goteborgs universitet distans
systemutvecklare malmö högskola

Kraftig ökning för Stenocare vid noteringen - Breakit

6,624.02. 2020-05-27 13:31:28 STENOCARE - Today is the first day of subscribing for the share issue-0,32% | 1,37 MDKK 2020-05-18 09:54:50 STENOCARE: I dag er første handelsdag på Nasdaq First North Growth Market Denmark +25,67% | 4,10 MDKK DenmarkSTENOCARE A/S(STENO) STENOCARE A/S. Denmark. STENOCARE A/S. 12.54.20 · First North Denmark.

Analys Stenocare - Game of stocks Cannabis danmark börsen

Our maximum online dealing fee to buy and sell shares is £11.95 per trade – deal regularly and this could fall to £5.95 per deal.

Six (6) subscription rights are required to subscribe for one new share in the issue.